Medacta Group SA
SIX:MOVE

Watchlist Manager
Medacta Group SA Logo
Medacta Group SA
SIX:MOVE
Watchlist
Price: 146 CHF -1.62% Market Closed
Market Cap: CHf2.9B

Medacta Group SA
Deferred Income Tax

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Medacta Group SA
Deferred Income Tax Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Deferred Income Tax CAGR 3Y CAGR 5Y CAGR 10Y
Medacta Group SA
SIX:MOVE
Deferred Income Tax
€61.2m
CAGR 3-Years
11%
CAGR 5-Years
11%
CAGR 10-Years
N/A
Metall Zug AG
SIX:METN
Deferred Income Tax
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Sonova Holding AG
SIX:SOON
Deferred Income Tax
CHf99.9m
CAGR 3-Years
-2%
CAGR 5-Years
-4%
CAGR 10-Years
11%
Straumann Holding AG
SIX:STMN
Deferred Income Tax
CHf62.8m
CAGR 3-Years
6%
CAGR 5-Years
8%
CAGR 10-Years
N/A
Medmix Ltd
SIX:MEDX
Deferred Income Tax
CHf15.7m
CAGR 3-Years
-1%
CAGR 5-Years
-10%
CAGR 10-Years
N/A
No Stocks Found

Medacta Group SA
Glance View

Market Cap
2.9B CHF
Industry
Health Care

Medacta Group SA, hailing from the picturesque setting of Castel San Pietro, Switzerland, stands as a prominent player in the global medical technology arena. Founded in 1999, the company has capitalized on a family-driven passion for innovation and precision in the orthopedic industry. Guided by its roots, Medacta designs and supplies orthopedic implants and surgical instruments, with a staunch focus on products for joint replacement, spine surgery, and sports medicine. But beyond mere manufacturing, Medacta combines cutting-edge research with in-depth medical training programs, ensuring that healthcare professionals are not only equipped with superior products but also with the necessary skills to optimize patient outcomes. The company’s MyPractice Development Plan exemplifies this by pairing technical support with educational efforts, fostering both confidence and competence among its professional clients. Medacta’s business model is a synthesis of product sales and continuous practitioner engagement. Revenue streams primarily flow from the direct sale of their extensive product portfolio, including implants and surgical instruments, to hospitals and surgical centers. However, Medacta's strategy extends its competitive advantage by nurturing strong relationships with medical professionals through training and support initiatives. This symbiotic approach ensures a feedback loop that not only tailors their offerings to the evolving needs of the marketplace but also solidifies client loyalty. Their innovative and educational initiatives secure a unique position in the market, allowing Medacta to maintain a balance of economic success and industry leadership by focusing on quality, innovation, and education.

MOVE Intrinsic Value
111.72 CHF
Overvaluation 23%
Intrinsic Value
Price CHf146

See Also

What is Medacta Group SA's Deferred Income Tax?
Deferred Income Tax
61.2m EUR

Based on the financial report for Dec 31, 2025, Medacta Group SA's Deferred Income Tax amounts to 61.2m EUR.

What is Medacta Group SA's Deferred Income Tax growth rate?
Deferred Income Tax CAGR 5Y
11%

Over the last year, the Deferred Income Tax growth was 25%. The average annual Deferred Income Tax growth rates for Medacta Group SA have been 11% over the past three years , 11% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett